Annual revenue:
$560.23M+$125.98M(+29.01%)Summary
- As of today (September 16, 2025), RARE annual revenue is $560.23 million, with the most recent change of +$125.98 million (+29.01%) on December 31, 2024.
- During the last 3 years, RARE annual revenue has risen by +$208.82 million (+59.43%).
- RARE annual revenue is now at all-time high.
Performance
RARE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$166.50M+$27.20M(+19.53%)Summary
- As of today (September 16, 2025), RARE quarterly revenue is $166.50 million, with the most recent change of +$27.20 million (+19.53%) on June 30, 2025.
- Over the past year, RARE quarterly revenue has increased by +$19.47 million (+13.24%).
- RARE quarterly revenue is now at all-time high.
Performance
RARE Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$610.16M+$19.47M(+3.30%)Summary
- As of today (September 16, 2025), RARE TTM revenue is $610.16 million, with the most recent change of +$19.47 million (+3.30%) on June 30, 2025.
- Over the past year, RARE TTM revenue has increased by +$128.86 million (+26.77%).
- RARE TTM revenue is now at all-time high.
Performance
RARE TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RARE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.0% | +13.2% | +26.8% |
| 3 y3 years | +59.4% | +86.4% | +82.5% |
| 5 y5 years | +440.2% | +169.8% | +282.8% |
RARE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.4% | at high | +86.4% | at high | +82.5% |
| 5 y | 5-year | at high | +440.2% | at high | +169.8% | at high | +282.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
RARE Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $166.50M(+19.5%) | $610.16M(+3.3%) |
| Mar 2025 | - | $139.29M(-15.5%) | $590.69M(+5.4%) |
| Dec 2024 | $560.23M(+29.0%) | $164.88M(+18.2%) | $560.23M(+7.2%) |
| Sep 2024 | - | $139.49M(-5.1%) | $522.75M(+8.6%) |
| Jun 2024 | - | $147.03M(+35.1%) | $481.30M(+8.7%) |
| Mar 2024 | - | $108.83M(-14.6%) | $442.59M(+1.9%) |
| Dec 2023 | $434.25M(+19.5%) | $127.39M(+29.9%) | $434.25M(+5.9%) |
| Sep 2023 | - | $98.05M(-9.5%) | $410.20M(+1.8%) |
| Jun 2023 | - | $108.31M(+7.8%) | $402.86M(+4.9%) |
| Mar 2023 | - | $100.50M(-2.8%) | $383.89M(+5.7%) |
| Dec 2022 | $363.33M(+3.4%) | $103.35M(+13.9%) | $363.33M(+5.8%) |
| Sep 2022 | - | $90.70M(+1.5%) | $343.37M(+2.7%) |
| Jun 2022 | - | $89.34M(+11.8%) | $334.31M(+0.7%) |
| Mar 2022 | - | $79.94M(-4.1%) | $331.95M(-5.5%) |
| Dec 2021 | $351.41M(+29.7%) | $83.39M(+2.1%) | $351.41M(-2.3%) |
| Sep 2021 | - | $81.65M(-6.1%) | $359.56M(+0.0%) |
| Jun 2021 | - | $86.97M(-12.5%) | $359.38M(+7.6%) |
| Mar 2021 | - | $99.39M(+8.6%) | $334.12M(+23.3%) |
| Dec 2020 | $271.03M(+161.3%) | $91.54M(+12.4%) | $271.03M(+26.0%) |
| Sep 2020 | - | $81.47M(+32.0%) | $215.08M(+34.9%) |
| Jun 2020 | - | $61.71M(+70.0%) | $159.41M(+30.8%) |
| Mar 2020 | - | $36.31M(+2.0%) | $121.85M(+17.5%) |
| Dec 2019 | $103.71M(+101.4%) | $35.59M(+38.0%) | $103.71M(+22.9%) |
| Sep 2019 | - | $25.80M(+6.8%) | $84.38M(+20.0%) |
| Jun 2019 | - | $24.15M(+32.9%) | $70.34M(+19.2%) |
| Mar 2019 | - | $18.17M(+11.8%) | $58.99M(+14.6%) |
| Dec 2018 | $51.49M | $16.26M(+38.2%) | $51.49M(+36.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $11.76M(-8.1%) | $37.65M(+44.3%) |
| Jun 2018 | - | $12.79M(+19.8%) | $26.08M(+96.3%) |
| Mar 2018 | - | $10.68M(+342.3%) | $13.29M(+408.8%) |
| Dec 2017 | $2.61M(+1863.9%) | $2.41M(+1119.2%) | $2.61M(+1186.7%) |
| Sep 2017 | - | $198.00K(>+9900.0%) | $203.00K(+75.0%) |
| Jun 2017 | - | $0.00(0.0%) | $116.00K(-12.8%) |
| Mar 2017 | - | $0.00(-100.0%) | $133.00K(0.0%) |
| Dec 2016 | $133.00K(>+9900.0%) | $5000.00(-95.5%) | $133.00K(+3.9%) |
| Sep 2016 | - | $111.00K(+552.9%) | $128.00K(+652.9%) |
| Jun 2016 | - | $17.00K(>+9900.0%) | $17.00K(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00 | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual revenue?
- What is the all time high annual revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual revenue year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly revenue?
- What is the all time high quarterly revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly revenue year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM revenue?
- What is the all time high TTM revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM revenue year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual revenue?
The current annual revenue of RARE is $560.23M
What is the all time high annual revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual revenue is $560.23M
What is Ultragenyx Pharmaceutical Inc. annual revenue year-on-year change?
Over the past year, RARE annual revenue has changed by +$125.98M (+29.01%)
What is Ultragenyx Pharmaceutical Inc. quarterly revenue?
The current quarterly revenue of RARE is $166.50M
What is the all time high quarterly revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly revenue is $166.50M
What is Ultragenyx Pharmaceutical Inc. quarterly revenue year-on-year change?
Over the past year, RARE quarterly revenue has changed by +$19.47M (+13.24%)
What is Ultragenyx Pharmaceutical Inc. TTM revenue?
The current TTM revenue of RARE is $610.16M
What is the all time high TTM revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM revenue is $610.16M
What is Ultragenyx Pharmaceutical Inc. TTM revenue year-on-year change?
Over the past year, RARE TTM revenue has changed by +$128.86M (+26.77%)